Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants

Exclusion Criteria

• •Heart rate that cannot be stabilized \>100 bpm within 5 minutes of birth
• •Five (5) minute Apgar score ≤ 3
• •Major congenital malformation(s) diagnosed antenatally or noted immediately after birth
• •Other disease(s) or conditions potentially interfering with cardiopulmonary function
• •Mother with prolonged rupture of membranes \> 2 weeks
• •Known or suspected chromosomal abnormality
• •Need for chest compressions or administration of epinephrine, bicarbonate, or fluid boluses in the delivery room
• •Need for mechanical ventilation within 30 minutes of birth